139 related articles for article (PubMed ID: 35854478)
1. IgM-enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices.
Immohr MB; Böttger C; Aubin H; Westenfeld R; Oehler D; Bruno RR; Dalyanoglu H; Tudorache I; Akhyari P; Lichtenberg A; Boeken U
ESC Heart Fail; 2022 Oct; 9(5):3630-3635. PubMed ID: 35854478
[TBL] [Abstract][Full Text] [Related]
2. Treatment of donor-specific antibody-mediated rejection after heart transplantation by IgM-enriched human immunoglobulin.
Immohr MB; Akhyari P; Aubin H; Westenfeld R; Mehdiani A; Bruno RR; Sipahi NF; Erbel-Khurtsidze S; Reinecke P; Tudorache I; Lichtenberg A; Boeken U
ESC Heart Fail; 2021 Aug; 8(4):3413-3417. PubMed ID: 33969938
[TBL] [Abstract][Full Text] [Related]
3. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
[TBL] [Abstract][Full Text] [Related]
4. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
[TBL] [Abstract][Full Text] [Related]
5. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
[TBL] [Abstract][Full Text] [Related]
6. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
[TBL] [Abstract][Full Text] [Related]
7. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
[TBL] [Abstract][Full Text] [Related]
8. Which advanced heart failure therapy strategy is optimal for patients over 60 years old?
Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V
J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306
[TBL] [Abstract][Full Text] [Related]
9. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Iron Deficiency and Iron Administration in Left Ventricular Assist Device and Heart Transplantation Patients.
Veenis JF; Radhoe SP; Roest S; Caliskan K; Constantinescu AA; Manintveld OC; Brugts JJ
ASAIO J; 2022 Jul; 68(7):899-906. PubMed ID: 34643575
[TBL] [Abstract][Full Text] [Related]
11. Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: Result of our case series.
Cikirikcioglu M; Ponchant K; Murith N; Meyer P; Yilmaz N; Huber C
Int J Artif Organs; 2021 Nov; 44(11):912-916. PubMed ID: 34558333
[TBL] [Abstract][Full Text] [Related]
12. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
[TBL] [Abstract][Full Text] [Related]
13. Effect of renal function under left ventricular assist device support on the cardiac function and clinical events after heart transplantation.
Kakuda N; Amiya E; Hatano M; Ishida J; Tsuji M; Bujo C; Yagi H; Fujita K; Ishii S; Isotani Y; Kurihara T; Numata G; Gyoten T; Shimada S; Ando M; Ono M; Komuro I
Clin Transplant; 2023 Dec; 37(12):e15107. PubMed ID: 37615650
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
Ammirati E; Brambatti M; Braun OÖ; Shah P; Cipriani M; Bui QM; Veenis J; Lee E; Xu R; Hong KN; Van de Heyning CM; Perna E; Timmermans P; Cikes M; Brugts JJ; Veronese G; Minto J; Smith S; Gjesdal G; Gernhofer YK; Partida C; Potena L; Masetti M; Boschi S; Loforte A; Jakus N; Milicic D; Nilsson J; De Bock D; Sterken C; Van den Bossche K; Rega F; Tran H; Singh R; Montomoli J; Mondino M; Greenberg B; Russo CF; Pretorius V; Liviu K; Frigerio M; Adler ED
Int J Cardiol; 2021 Feb; 324():122-130. PubMed ID: 32950592
[TBL] [Abstract][Full Text] [Related]
15. Heart transplantation in the patient under ventricular assist complicated with device-related infection.
Wang SS; Chou NK; Hsu RB; Ko WJ; Yu HY; Chen YS; Huang SC; Chi NH; Liau CS; Lee YT
Transplant Proc; 2004 Oct; 36(8):2377-9. PubMed ID: 15561254
[TBL] [Abstract][Full Text] [Related]
16. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
[TBL] [Abstract][Full Text] [Related]
17. Bowel obstruction due to retained intraperitoneal left ventricular assist device (LVAD) driveline.
Miklin D; Lewis I; Lieberman H
J Cardiothorac Surg; 2018 May; 13(1):46. PubMed ID: 29783995
[TBL] [Abstract][Full Text] [Related]
18. Complex HeartWare left ventricular assist device infection treated with pump exchange: clinical alert for the driveline location.
Domae K; Toda K; Yoshioka D; Miyagawa S; Yoshikawa Y; Hata H; Kainuma S; Kawamura T; Kawamura A; Sawa Y
J Artif Organs; 2021 Sep; 24(3):377-381. PubMed ID: 33439371
[TBL] [Abstract][Full Text] [Related]
19. Successful experience in bridging patients to heart transplantation with the MicroMed DeBakey ventricular assist device.
Vitali E; Lanfranconi M; Ribera E; Bruschi G; Colombo T; Frigerio M; Russo C
Ann Thorac Surg; 2003 Apr; 75(4):1200-4. PubMed ID: 12683563
[TBL] [Abstract][Full Text] [Related]
20. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
